[{"address1": "4902 Eisenhower Boulevard", "address2": "Suite 125", "city": "Tampa", "state": "FL", "zip": "33634", "country": "United States", "phone": "813 286 7900", "fax": "813 286 7904", "website": "https://www.oragenics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The company also develops NT-CoV2-1, a SARS-CoV-2 vaccine product candidate; and Lantibiotic Product Candidate, such as Mutacin 1140 (MU1140), a molecule belonging to the novel class of antibiotics. It has a license agreement with Inspirevax Inc. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Tampa, Florida.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Mr. Charles L. Pope CPA", "age": 72, "title": "Executive Chairman", "yearBorn": 1952, "fiscalYear": 2023, "totalPay": 112500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Janet  Huffman", "age": 51, "title": "Interim CEO & CFO", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 314896, "exercisedValue": 0, "unexercisedValue": 4554}, {"maxAge": 1, "name": "Dr. James P. Kelly M.A., M.D.", "title": "Chief Medical Officer & Member of Scientific Advisor", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. William Franklin Peacock IV, F.A.C.E.P., FACC, M.D.", "title": "Chief Clinical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Christine M. Farrell", "age": 64, "title": "Vice President of Finance", "yearBorn": 1960, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "irWebsite": "http://www.oragenics.com/?q=investors", "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.2828, "open": 0.294, "dayLow": 0.285, "dayHigh": 0.2899, "regularMarketPreviousClose": 0.2828, "regularMarketOpen": 0.294, "regularMarketDayLow": 0.285, "regularMarketDayHigh": 0.2899, "payoutRatio": 0.0, "beta": 0.377, "forwardPE": -0.026453702, "volume": 396475, "regularMarketVolume": 396475, "averageVolume": 5496245, "averageVolume10days": 2221570, "averageDailyVolume10Day": 2221570, "bid": 0.2856, "ask": 0.2857, "bidSize": 32, "askSize": 9, "marketCap": 3916889, "fiftyTwoWeekLow": 0.25, "fiftyTwoWeekHigh": 3.47, "priceToSalesTrailing12Months": "Infinity", "fiftyDayAverage": 0.3274, "twoHundredDayAverage": 0.7968, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2421812, "profitMargins": 0.0, "floatShares": 9398634, "sharesOutstanding": 13709800, "sharesShort": 2134158, "sharesShortPriorMonth": 634588, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.1557, "heldPercentInsiders": 0.23388, "heldPercentInstitutions": 0.020580001, "shortRatio": 3.97, "shortPercentOfFloat": 0.1879, "impliedSharesOutstanding": 13709800, "bookValue": 0.158, "priceToBook": 1.8082278, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -19966224, "trailingEps": -6.97, "forwardEps": -10.8, "lastSplitFactor": "1:60", "lastSplitDate": 1674432000, "enterpriseToEbitda": -0.121, "52WeekChange": -0.91463417, "SandP52WeekChange": 0.2021538, "quoteType": "EQUITY", "currentPrice": 0.2857, "recommendationKey": "none", "totalCash": 3144049, "totalCashPerShare": 0.257, "ebitda": -19979164, "totalDebt": 519392, "quickRatio": 1.479, "currentRatio": 1.934, "totalRevenue": 0, "debtToEquity": 16.877, "revenuePerShare": 0.0, "returnOnAssets": -1.9078599, "returnOnEquity": -4.1705303, "grossProfits": -13491215, "freeCashflow": -9789655, "operatingCashflow": -7681574, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "OGEN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Oragenics Inc.", "longName": "Oragenics, Inc.", "marketState": "REGULAR", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "esgPopulated": false, "regularMarketChangePercent": 1.0254596, "regularMarketPrice": 0.2857, "regularMarketChange": 0.0029, "regularMarketDayRange": "0.285 - 0.2899", "fullExchangeName": "NYSE American", "averageDailyVolume3Month": 5496245, "fiftyTwoWeekLowChange": 0.035699993, "fiftyTwoWeekLowChangePercent": 0.14279997, "fiftyTwoWeekRange": "0.25 - 3.47", "fiftyTwoWeekHighChange": -3.1843, "fiftyTwoWeekHighChangePercent": -0.91766566, "fiftyTwoWeekChangePercent": -91.46342, "dividendDate": 1516579200, "earningsTimestampStart": 1743105600, "earningsTimestampEnd": 1743451200, "isEarningsDateEstimate": true, "corporateActions": [], "regularMarketTime": 1740169118, "exchange": "ASE", "messageBoardId": "finmb_774436", "market": "us_market", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1077719400000, "epsTrailingTwelveMonths": -6.97, "epsForward": -10.8, "fiftyDayAverageChange": -0.041700006, "fiftyDayAverageChangePercent": -0.12736715, "twoHundredDayAverageChange": -0.51110005, "twoHundredDayAverageChangePercent": -0.6414408, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "displayName": "Oragenics", "trailingPegRatio": null, "__fetch_time": "2025-02-21"}]